Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4 Pancreatic Neoplasms 3 Carcinoma, Hepatocellular 2 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Pancreatic Adenocarcinoma Locally Advanced 1 Melanoma 1 Lymphatic Metastasis 1 Liver Diseases 1 HIV Seropositivity 1

Interventions

Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Indocyanine Green 2 Conversion to Open Surgery 2 Cisplatin 2 Artificial Intelligence 2 tislelizumab 1 radium Ra 223 dichloride 1 peposertib 1 pembrolizumab 1 lncRNA LNMAT1, human 1 encorafenib 1 cabozantinib 1 binimetinib 1 avelumab 1 alovudine 1 X-Rays 1 Technetium-99 1 Technetium 1 Surgical Procedures, Operative 1 Sentinel Lymph Node Biopsy 1 Robotic Surgical Procedures 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Propranolol 1 Platinum Compounds 1 Platinum 1 Pemetrexed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphatic Metastasis × Electroporation × 1 year × Clear all

NCT07328243 2026-01-09

IRE-TCLN

First Affiliated Hospital of Zhejiang University

Phase NA Recruiting

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡